Explore more publications!

Press Releases

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering  Including Full Exercise of Underwriter Option
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dr. Madeline Camejo Selected for Top Chief Pharmacy Officer of the Decade by IAOTP
2026 CORPORATE TAX REGISTRATION: How The VAT Consultant Is Future-Proofing UAE Businesses for Next Era of Compliance.
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
CodeSol Technologies Helps Businesses in Austin, Texas Save 1,000+ Hours Annually with Workflow Automation
WIRX Pharmacy Data Breach Claims Investigated by Lynch Carpenter
Top Technology Executives Recognized at the 2026 Ohio CIO ORBIE Awards
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Lessing’s Hospitality Group Opens Shoreline Café at Catholic Health’s Good Samaritan University Hospital in West Islip, NY
Sadhguru Presents Innovative AI Hologram Tech at Massive Event
ICYMI: Under Governor Josh Shapiro, Pennsylvania’s Life Science Industry is Growing at Record Speed

ICYMI: Under Governor Josh Shapiro, Pennsylvania’s Life Science Industry is Growing at Record Speed

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
ICYMI: Under Governor Josh Shapiro, Pennsylvania’s Life Science Industry is Growing at Record Speed

ICYMI: Under Governor Josh Shapiro, Pennsylvania’s Life Science Industry is Growing at Record Speed

Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
FHE Health Marks 25 Years of Growth, Innovation, and Purpose in Behavioral Healthcare
Rafferty Domnick Cunningham & Yaffa Calls for Stronger Oversight as Florida’s Med Spa Industry Outpaces Regulation
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
Attor­ney Gen­er­al Ken Pax­ton Sues Rad­i­cal Com­pa­ny Sell­ing Harm­ful Chest Binders to Girls to ​“Tran­si­tion” Them

Attor­ney Gen­er­al Ken Pax­ton Sues Rad­i­cal Com­pa­ny Sell­ing Harm­ful Chest Binders to Girls to ​“Tran­si­tion” Them

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions